What is the treatment for Extrapyramidal Symptoms (EPS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Extrapyramidal Symptoms (EPS)

Anticholinergic medications are the first-line treatment for extrapyramidal symptoms, with benztropine 1-4 mg daily being the most effective option for acute drug-induced EPS. 1

First-Line Treatments Based on EPS Type

Acute Dystonia

  • Administer benztropine 1-2 mg orally or parenterally, which usually provides quick relief 1
  • Continue with benztropine 1-2 mg twice daily to prevent recurrence 1
  • For severe or life-threatening dystonic reactions (such as laryngeal dystonia), parenteral administration is preferred for rapid response 1, 2

Drug-Induced Parkinsonism

  • Start benztropine 1-2 mg orally 2-3 times daily 1
  • Dosage must be individualized according to patient needs, with a maximum of 6 mg daily 1
  • After 1-2 weeks, attempt to withdraw the medication to determine continued need 1, 3

Akathisia

  • Consider beta-blockers (particularly propranolol) as they appear most effective for akathisia 2
  • Benzodiazepines may be used as an alternative 2
  • Anticholinergics like benztropine may be less effective for akathisia but can still be tried 2

Alternative Approaches

Medication Adjustments

  • Reduce the dose of the offending antipsychotic if clinically appropriate 2
  • Consider switching to an atypical antipsychotic with lower EPS risk (such as olanzapine, quetiapine, or clozapine) 4, 2
  • Avoid high doses of even atypical antipsychotics, as they can still cause EPS at higher doses 3

Alternative Medications

  • Amantadine can be used as an alternative to anticholinergics for drug-induced parkinsonism 2
  • For akathisia resistant to first-line treatments, consider adding a benzodiazepine 2

Special Considerations

Duration of Treatment

  • For acute dystonic reactions, continue treatment for at least 1-2 weeks after the initial episode 1
  • For drug-induced parkinsonism, attempt to withdraw anticholinergic medication after 2 weeks to determine continued need 1, 3
  • Long-term use of anticholinergic medications is not recommended unless symptoms recur upon withdrawal 3

Prevention Strategies

  • Prophylactic anticholinergic treatment should be considered only for high-risk patients (young males, those with previous EPS) 3, 2
  • If prophylactic treatment is initiated, it should be discontinued after at least two weeks 3
  • Use the lowest effective dose of antipsychotics to minimize EPS risk 4, 2

Monitoring

  • Regularly assess for early signs of EPS to allow prompt intervention 4
  • Monitor for anticholinergic side effects (dry mouth, blurred vision, constipation, urinary retention) 1

Pitfalls to Avoid

  • Do not continue anticholinergic medications indefinitely without attempting withdrawal, as long-term use adds unnecessary side effect burden 3
  • Avoid routine prophylactic use of anticholinergics for all patients on antipsychotics 3
  • Don't overlook that even atypical antipsychotics can cause EPS, especially at higher doses 3, 5
  • Never misinterpret akathisia as anxiety or psychotic agitation, as this can lead to inappropriate treatment 4

References

Research

Management of acute extrapyramidal effects induced by antipsychotic drugs.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1997

Guideline

Extrapyramidal Symptoms: Causes, Risk Factors, and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.